NelGaard Capital is a Pre-Seed and Seed-stage Venture Architect firm. We specialize in identifying platform technologies that solve the massive infrastructure constraints of the modern era.

Our philosophy is built on AI-driven Velocity: leveraging computational modeling and programmable biology to collapse the traditional 10-year development cycle into high-velocity commercial pivots.

Our Track Record of Conviction.  With a history of generating a 166% IRR and 39x returns, our team combines deep scientific rigor with the precision of institutional investment banking. We don’t just evaluate deals; we build them from the ground up.

The Venture Architect Model. Our approach is hands-on and infrastructure-centric. We act as a "Founding Engine" for our portfolio companies:

IP Fortress Building: We lead the assembly and protection of core intellectual property.

Strategic Spin-outs: We specialize in identifying and acquiring latent assets to pivot them toward public market readiness.

Industrial Partnerships: We forge transformative alliances—like our work with GenScript—to ensure our platforms reach commercial scale rapidly.

Operational Leadership: We recruit elite leadership and provide the strategic governance required to navigate the path from Seed to IPO or M&A.

Portfolio Highlights: Infrastructure for the Next Century
NelGaard is the architect behind a new generation of "Frontier TechBio" platforms:

Mimulus Corp: Solving the global data crisis by industrializing Molecular Archive Technology™. By combining CMOS technology with synthetic biology, Mimulus is creating the world's first carbon-neutral, century-scale archival storage system.

Cellari Therapeutics: Redefining mRNA-based neuromodulation. By targeting the SNARE pathway with programmable therapeutics, Cellari is building the next generation of neuromodulators.

Racer Biosciences: Revolutionizing synthetic biology workflows.

NelGaard Capital

Org chart

Teams

Offices